Literature DB >> 23060559

Tissue distribution of (Lipocurc™) liposomal curcumin and tetrahydrocurcumin following two- and eight-hour infusions in Beagle dogs.

Dharmendr Matabudul1, Kresimir Pucaj, Gordon Bolger, Brigitta Vcelar, Muhammed Majeed, Lawrence Helson.   

Abstract

This study interrogated whether different durations of intravenous infusions of lipocurc™ would alter curcumin metabolism, tissue distribution and whether treating necropsied tissues of Beagle dogs with phosphoric acid prior to measuring curcumin and its metabolite, tetrahydrocurcumin (THC), would stabilize the compounds allowing for accurate analytic measurements. Two cohorts comprising two male and two female dogs were infused each intravenously with 10 mg/kg lipocurc™, either over two hours or over eight hours. Tissue data from each cohort was averaged from four dogs. Curcumin and THC distributed among all 13 tissues were examined at necropsy. The highest curcumin level was observed in the lungs followed by the liver. Tissue levels of curcumin in the lung, spleen and liver increased substantially following the eight-hour infusion compared to the two-hour infusion. The pancreas, kidney and urinary bladder also contained relatively high curcumin levels. Tissue partition coefficients for curcumin and THC were also higher for the eight-hour infusion than the two-hour infusion. The tissue THC/curcumin ratio varied in a tissue-specific manner and was lower for the eight-hour compared to the two-hour infusion. In conclusion, this raised the possibility that prolonged infusion of curcumin may facilitate distribution into tissues via a transporter-dependent mechanism and elevated tissue concentrations of curcumin may inhibit or saturate a putative reductase enzyme converting curcumin to THC. The addition of phosphoric acid stabilized the levels of curcumin and THC in some but not all the examined tissues, raising issues of tissue-specific curcumin and THC stability.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23060559

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  In vitro and in vivo activity of liposome-encapsulated curcumin for naturally occurring canine cancers.

Authors:  Sita S Withers; Daniel York; Eric Johnson; Sami Al-Nadaf; Katherine A Skorupski; Carlos O Rodriguez; Jenna H Burton; Teri Guerrero; Kriste Sein; Luke Wittenburg; Robert B Rebhun
Journal:  Vet Comp Oncol       Date:  2018-08-08       Impact factor: 2.613

2.  Curcumin Modulates Pancreatic Adenocarcinoma Cell-Derived Exosomal Function.

Authors:  Carlos J Diaz Osterman; James C Lynch; Patrick Leaf; Amber Gonda; Heather R Ferguson Bennit; Duncan Griffiths; Nathan R Wall
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

3.  The Safety and Exploration of the Pharmacokinetics of Intrapleural Liposomal Curcumin.

Authors:  Ashleigh Hocking; Sara Tommasi; Peter Sordillo; Sonja Klebe
Journal:  Int J Nanomedicine       Date:  2020-02-11

4.  Bioanalytical method by HPLC-FLD for curcumin analysis in supplemented athletes.

Authors:  Alisson Henrique Antunes; Flávia Rasmussen Faria; João Felipe Mota; Mariângela Fontes Santiago; Ana Carolina Kogawa; Kênnia Rocha Rezende
Journal:  Saudi Pharm J       Date:  2020-04-02       Impact factor: 4.330

5.  Study protocol of a phase 1 clinical trial establishing the safety of intrapleural administration of liposomal curcumin: curcumin as a palliative treatment for malignant pleural effusion (IPAL-MPE).

Authors:  Ashleigh Jean Hocking; Alexandra L Farrall; Sarah Newhouse; Peter Sordillo; Kim Greco; Christos Stelios Karapetis; Brendan Dougherty; Sonja Klebe
Journal:  BMJ Open       Date:  2021-03-29       Impact factor: 2.692

Review 6.  The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders.

Authors:  Priti Tagde; Pooja Tagde; Fahadul Islam; Sandeep Tagde; Muddaser Shah; Zareen Delawar Hussain; Md Habibur Rahman; Agnieszka Najda; Ibtesam S Alanazi; Mousa O Germoush; Hanan R H Mohamed; Mardi M Algandaby; Mohammed Z Nasrullah; Natalia Kot; Mohamed M Abdel-Daim
Journal:  Molecules       Date:  2021-11-24       Impact factor: 4.411

Review 7.  Nanotechnology-applied curcumin for different diseases therapy.

Authors:  Negar Ghalandarlaki; Ali Mohammad Alizadeh; Soheil Ashkani-Esfahani
Journal:  Biomed Res Int       Date:  2014-06-05       Impact factor: 3.411

8.  The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats.

Authors:  Adriana E Bulboacă; Sorana D Bolboacă; Ioana C Stănescu; Carmen A Sfrângeu; Alina Porfire; Lucia Tefas; Angelo C Bulboacă
Journal:  Int J Nanomedicine       Date:  2018-05-25

Review 9.  The Cancer Chemopreventive and Therapeutic Potential of Tetrahydrocurcumin.

Authors:  Ching-Shu Lai; Chi-Tang Ho; Min-Hsiung Pan
Journal:  Biomolecules       Date:  2020-05-29

10.  A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc) in patients with locally advanced or metastatic cancer.

Authors:  Richard Greil; Sigrun Greil-Ressler; Lukas Weiss; Charlotte Schönlieb; Teresa Magnes; Bianca Radl; Gordon T Bolger; Brigitta Vcelar; Peter P Sordillo
Journal:  Cancer Chemother Pharmacol       Date:  2018-08-03       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.